Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

5,000 patients to help unlock secrets of inflammatory heart disease

NCT ID NCT07077304

Knowledge-focused Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to learn how well heart scans (MRI, ultrasound, PET) can detect and predict outcomes in people with suspected or known inflammatory heart diseases. Researchers will follow 5,000 adults for one year to see how often heart involvement is confirmed and how it affects health. No new treatments are being tested; the goal is to improve diagnosis and understanding.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 5,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2025

Expected to finish

Oct 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

all patients with a suspicion of cardiovascular involvement due to a suspected or previously diagnosed ICARD referred for a CMR and/or nuclear imaging exam.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Age ≥ 18 years 2. Ability to provide informed non-opposition 3. Referred for a CMR and/or nuclear imaging exam AND a suspicion of one of the following ICARDs : 1. Suspected Myocarditis (acute or chronic, and whatever the aetiologies) 2. Suspected Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA) 3. Suspected Tako-Tsubo 4. Suspected Pericarditis (acute or chronic, and whatever the aetiologies) 5. Suspected Connective tissue disease with cardiovascular involvement: * Systemic sclerosis * Systemic lupus erythematosus * Antiphospholipid syndrome * Idiopathic inflammatory myopathies * Rheumatoid arthritis, spondylarthritis 6. Suspected Vasculitis with cardiovascular involvement: * Small-vessel vasculitis (ANCA…) * Large vessel vasculitis (Behcet disease, Takayasu…) 7. Suspected Inflammatory disease with cardiovascular involvement: * Sarcoidosis * Still disease Exclusion Criteria: 1. Inability to provide non-opposition 2. History of heart transplant

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANCA associated vasculitis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

acquired idiopathic inflammatory myopathy anti-neutrophil cytoplasmic antibody-associated vasculitis Behcet disease cardiovascular disorder granulomatosis with polyangiitis juvenile idiopathic arthritis myocarditis myositis disease pericarditis rheumatic disorder rheumatoid arthritis sarcoidosis Spondylarthritis spondyloarthropathy systemic lupus erythematosus systemic sclerosis systemic-onset juvenile idiopathic arthritis Takayasu arteritis Tako-tsubo cardiomyopathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANCA associated vasculitis Behcet disease Idiopathic inflammatory myopathies Myocarditis Pericarditis Rheumatoid arthritis Sarcoidosis Spondylarthritis Still disease Systemic lupus erythematosus Systemic sclerosis Takayasu arteritis Tako tsubo cardiomyopathy

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Assistance Publique Hôpitaux de Paris, Paris, île de France 75010

    RECRUITING

    Paris, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.